Imaging of small animal peripheral artery disease models: Recent advancements and translational potential

International Journal of Molecular Sciences

Volumn 16, Issue 5, 2015, Pages 11131-11177

  Lin, Jenny B ^a   Phillips, Evan H ^a   Riggins, Ti’Air E ^a   Sangha, Gurneet S ^a   Chakraborty, Sreyashi ^b   Lee, Janice Y ^b   Lycke, Roy J ^a   Hernandez, Clarissa L ^a   Soepriatna, Arvin H ^a   Thorne, Bradford R H ^b   Yrineo, Alexa A ^a   Goergen, Craig J ^a  

^a PURDUE UNIVERSITY   (United States)

^b PURDUE UNIVERSITY   (United States)

Author keywords

Aneurysm; Atherosclerosis; Computed tomography; Ischemia; Magnetic resonance; Optical imaging; Peripheral artery disease; Small animal model; Stroke; Ultrasound

Indexed keywords

ACTIVIN RECEPTOR LIKE KINASE 1; CYTOKINE; ELASTIN; ENDOTHELIAL NITRIC OXIDE SYNTHASE; LOW DENSITY LIPOPROTEIN; MATRIX METALLOPROTEINASE; NANOPARTICLE; VASCULOTROPIN;

ABDOMINAL AORTA ANEURYSM; ANIMAL MODEL; ATHEROSCLEROTIC PLAQUE; BLOOD FLOW VELOCITY; BRAIN ARTERIOVENOUS MALFORMATION; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CAROTID ARTERY OBSTRUCTION; CAROTID ATHEROSCLEROSIS; DIAGNOSTIC IMAGING; FLUORESCENCE IMAGING; GATED SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY; HEART HEMODYNAMICS; INTRACRANIAL ANEURYSM; LEG THROMBOSIS; MAGNETIC RESONANCE ANGIOGRAPHY; MICRO-COMPUTED TOMOGRAPHY; NEAR INFRARED IMAGING SYSTEM; NONHUMAN; PARTICLE IMAGE VELOCIMETRY; PATHOPHYSIOLOGY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PHOTOACOUSTIC TOMOGRAPHY; POSITRON EMISSION TOMOGRAPHY; REVIEW; SCINTISCANNING; THORACIC AORTA ANEURYSM; ULTRASOUND; ANIMAL; AORTIC DISEASES; CEREBROVASCULAR DISORDERS; DISEASE MODEL; ECHOGRAPHY; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PERIPHERAL ARTERIAL DISEASE; THROMBOSIS; X-RAY COMPUTED TOMOGRAPHY;

ANIMALIA; MUS; ORYCTOLAGUS CUNICULUS; RATTUS; RODENTIA;

ANIMALS; AORTIC DISEASES; CEREBROVASCULAR DISORDERS; DISEASE MODELS, ANIMAL; HUMANS; MAGNETIC RESONANCE IMAGING; OPTICAL IMAGING; PERIPHERAL ARTERIAL DISEASE; THROMBOSIS; TOMOGRAPHY, X-RAY COMPUTED; ULTRASONOGRAPHY;

EID: 84930615684     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms160511131     Document Type: Review

References (259)

1. Hiatt, W.R. Medical treatment of peripheral arterial disease and claudication. N. Engl. J. Med. 2001, 344, 1608–1621.
2. Valentine, R.J.; Decaprio, J.D.; Castillo, J.M.; Modrall, J.G.; Jackson, M.R.; Clagett, G.P. Watchful waiting in cases of small abdominal aortic aneurysms- appropriate for all patients? J. Vasc. Surg. 2000, 32, 441–448; discussion 448–450.
3. Ferdowsian, H.R.; Beck, N. Ethical and scientific considerations regarding animal testing and research. PLoS ONE 2011, 6, e24059.
4. Liu, B.; Tang, D. Computer simulations of atherosclerotic plaque growth in coronary arteries. Mol. Cell. Biomech. 2010, 7, 193–202.
5. Botnar, R.; Rappitsch, G.; Scheidegger, M.B.; Liepsch, D.; Perktold, K.; Boesiger, P. Hemodynamics in the carotid artery bifurcation: A comparison between numerical simulations and in vitro mri measurements. J. Biomech. 2000, 33, 137–144.
6. Munir, J.A. Atherosclerosis: Clinical Perspectives through Imaging; Taylor, A.J., Villines, T.C., Eds.; Springer: New York, NY, USA, 2013; p. 233.
7. Falk, E. Pathogenesis of atherosclerosis. J. Am. Coll. Cardiol. 2006, 47, C7–C12.
8. Naghavi, M.; Libby, P.; Falk, E.; Casscells, S.W.; Litovsky, S.; Rumberger, J.; Badimon, J.J.; Stefanadis, C.; Moreno, P.; Pasterkamp, G.; et al. From vulnerable plaque to vulnerable patient: A call for new definitions and risk assessment strategies: Part I. Circulation 2003, 108, 1664–1672.
9. Glagov, S.; Zarins, C.; Giddens, D.P.; Ku, D.N. Hemodynamics and atherosclerosis. Insights and perspectives gained from studies of human arteries. Arch. Pathol. Lab. Med. 1988, 112, 1018–1031.
10. Ku, D.N. Blood flow in arteries. Annu. Rev. Fluid Mech. 1997, 29, 399–434.
11. Go, A.S.; Mozaffarian, D.; Roger, V.L.; Benjamin, E.J.; Berry, J.D.; Blaha, M.J.; Dai, S.; Ford, E.S.; Fox, C.S.; Franco, S.; et al. Executive summary: Heart disease and stroke statistics—2014 update: A report from the american heart association. Circulation 2014, 129, 399–410.
12. O’Leary, D.H.; Polak, J.F.; Kronmal, R.A.; Manolio, T.A.; Burke, G.L.; Wolfson, S.K., Jr.. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular health study collaborative research group. N. Engl. J. Med. 1999, 340, 14–22.
13. Hertzer, N.R.; Beven, E.G.; Young, J.R.; O’Hara, P.J.; Ruschhaupt, W.F., 3rd; Graor, R.A.; Dewolfe, V.G.; Maljovec, L.C. Coronary artery disease in peripheral vascular patients. A classification of 1000 coronary angiograms and results of surgical management. Ann. Surg. 1984, 199, 223–233.
14. Hertzer, N.R.; Young, J.R.; Beven, E.G.; Graor, R.A.; O’Hara, P.J.; Ruschhaupt, W.F., 3rd; deWolfe, V.G.; Maljovec, L.C. Coronary angiography in 506 patients with extracranial cerebrovascular disease. Arch. Intern. Med. 1985, 145, 849–852.
15. Lin, J.S.; Olson, C.M.; Johnson, E.S.; Senger, C.A.; Soh, C.B.; Whitlock, E.P. The Ankle Brachial Index for Peripheral Artery Disease Screening and Cardiovascular Disease Prediction in Asymptomatic Adults: A Systematic Evidence Review for the U.S. Preventive Services Task Force; Agency for Healthcare Research and Quality (US): Rockville, MD, USA, 2013.
16. Madamanchi, N.R.; Vendrov, A.; Runge, M.S. Oxidative stress and vascular disease. Arterioscler. Thromb. Vasc. Biol. 2005, 25, 29–38.
17. Kuhlencordt, P.J.; Gyurko, R.; Han, F.; Scherrer-Crosbie, M.; Aretz, T.H.; Hajjar, R.; Picard, M.H.; Huang, P.L. Accelerated atherosclerosis, aortic aneurysm formation, and ischemic heart disease in apolipoprotein E/endothelial nitric oxide synthase double-knockout mice. Circulation 2001, 104, 448–454.
18. Agarwal, S.; Naderi, S. Etiopathogenic differences in coronary artery disease and peripheral artery disease: Results from the national health and nutrition examination survey. Angiology 2014, 65, 883–890.
19. Ripa, R.S.; Kjaer, A.; Hesse, B. Non-invasive imaging for subclinical coronary atherosclerosis in patients with peripheral artery disease. Curr. Atheroscler. Rep. 2014, 16, 415.
20. Hussein, A.A.; Uno, K.; Wolski, K.; Kapadia, S.; Schoenhagen, P.; Tuzcu, E.M.; Nissen, S.E.; Nicholls, S.J. Peripheral arterial disease and progression of coronary atherosclerosis. J. Am. Coll. Cardiol. 2011, 57, 1220–1225.
21. Eraso, L.H.; Fukaya, E.; Mohler, E.R.; Xie, D.; Sha, D.; Berger, J.S. Peripheral arterial disease, prevalence and cumulative risk factor profile analysis. Eur. J. Prev. Cardiol. 2012, 21, 704–711.
22. Murabito, J.M.; D’Agostino, R.B.; Silbershatz, H.; Wilson, W.F. Intermittent claudication. A risk profile from the framingham heart study. Circulation 1997, 96, 44–49.
23. Fowkes, F.G.R.; Rudan, D.; Rudan, I.; Aboyans, V.; Denenberg, J.O.; McDermott, M.M.; Norman, P.E.; Sampson, U.K.A.; Williams, L.J.; Mensah, G.A.; et al. Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: A systematic review and analysis. Lancet 2013, 382, 1329–1340.
24. Diehm, C.; Schuster, A.; Allenberg, J.R.; Darius, H.; Haberl, R.; Lange, S.; Pittrow, D.; von Stritzky, B.; Tepohl, G.; Trampisch, H.-J. High prevalence of peripheral arterial disease and co-morbidity in 6880 primary care patients: Cross-sectional study. Atherosclerosis 2004, 172, 95–105.
25. Formosa, C.; Cassar, K.; Gatt, A.; Mizzi, A.; Mizzi, S.; Camileri, K.P.; Azzopardi, C.; DeRaffaele, C.; Falzon, O.; Cristina, S.; et al. Hidden dangers revealed by misdiagnosed peripheral arterial disease using ABPI measurement. Diabetes Res. Clin. Pract. 2013, 102, 112–116.
26. Sampson, U.K.; Norman, P.E.; Fowkes, F.G.; Aboyans, V.; Song, Y.; Harrell, F.E., Jr.; Forouzanfar, M.H.; Naghavi, M.; Denenberg, J.O.; McDermott, M.M.; et al. Estimation of global and regional incidence and prevalence of abdominal aortic aneurysms 1990 to 2010. Glob. Heart 2014, 9, 159–170.
27. Brisman, J.L.; Song, J.K.; Newell, D.W. Cerebral aneurysms. N. Engl. J. Med. 2006, 355, 928–939.
28. Redekop, G.; TerBrugge, K.; Montanera, W.; Willinsky, R. Arterial aneurysms associated with cerebral arteriovenous malformations: Classification, incidence, and risk of hemorrhage. J. Neurosurg. 1998, 89, 539–546.
29. Da Costa, L.; Wallace, M.C.; Ter Brugge, K.G.; O’Kelly, C.; Willinsky, R.A.; Tymianski, M. The natural history and predictive features of hemorrhage from brain arteriovenous malformations. Stroke J. Cereb. Circ. 2009, 40, 100–105.
30. Hai, J.; Ding, M.; Guo, Z.; Wang, B. A new rat model of chronic cerebral hypoperfusion associated with arteriovenous malformations. J. Neurosurg. 2002, 97, 1198–1202.
31. Hai, J.; Wu, Y.; Lin, Q.; Huang, X.; Zhang, G. Cerebral blood flow and metabolic changes in hippocampal regions of a modified rat model with chronic cerebral hypoperfusion. Acta Neurol. Belg. 2013, 113, 313–317.
32. Sadasivan, C.; Fiorella, D.J.; Woo, H.H.; Lieber, B.B. Physical factors effecting cerebral aneurysm pathophysiology. Ann. Biomed. Eng. 2013, 41, 1347–1365.
33. Thompson, R.W.; Curci, J.A.; Ennis, T.L.; Mao, D.; Pagano, M.B.; Pham, C.T. Pathophysiology of abdominal aortic aneurysms: Insights from the elastase-induced model in mice with different genetic backgrounds. Ann. N. Y. Acad. Sci. 2006, 1085, 59–73.
34. Fowkes, F.G.R.; Murray, G.D.; Butcher, I.; Heald, C.L.; Lee, R.J.; Chambless, L.E.; Folsom, A.R.; Hirsch, A.T.; Dramaix, M.; deBacker, G.; et al. Ankle brachial index combined with framingham risk score to predict cardiovascular events and mortality: A meta-analysis. JAMA 2008, 300, 197–208.
35. Feigin, V.L.; Lawes, C.M.; Bennett, D.A.; Anderson, C.S. Stroke epidemiology: A review of population-based studies of incidence, prevalence, and case-fatality in the late 20th century. Lancet Neurol. 2003, 2, 43–53.
36. Hackett, M.L.; Anderson, C.S. Health outcomes 1 year after subarachnoid hemorrhage: An international population-based study. The australian cooperative research on subarachnoid hemorrhage study group. Neurology 2000, 55, 658–662.
37. Hiratzka, L.F.; Bakris, G.L.; Beckman, J.A.; Bersin, R.M.; Carr, V.F.; Casey, D.E., Jr.; Eagle, K.A.; Hermann, L.K.; Isselbacher, E.M.; et al. Guidelines for the diagnosis and management of patients with thoracic aortic disease. A report of the american college of cardiology foundation/american heart association task force on practice guidelines, american association for thoracic surgery, american college of radiology,american stroke association, society of cardiovascular anesthesiologists, society for cardiovascular angiography and interventions, society of interventional radiology, society of thoracic surgeons,and society for vascular medicine. J. Am. Coll. Cardiol. 2010, 55, e27–e129.
38. Al-Shahi, R.; Warlow, C. A systematic review of the frequency and prognosis of arteriovenous malformations of the brain in adults. Brain: J. Neurol. 2001, 124, 1900–1926.
39. Howard, G.; Goff, D.C. Population shifts and the future of stroke: Forecasts of the future burden of stroke. Ann. N. Y. Acad. Sci. 2012, 1268, 14–20.
40. Balaban, R.S.; Hampshire, V.A. Challenges in small animal noninvasive imaging. ILAR J/Natl. Res. Counc. Inst. Lab. Anim. Resour. 2001, 42, 248–262.
41. Webb, A.; Kagadis, G.C. Introduction to Biomedical Imaging; Wiley Interscience-IEEE: Hoboken, NJ, USA, 2003.
42. Lee, G.H.; Chang, Y.; Kim, T.J. Blood‐pool and targeting MRI contrast agents: From Gd‐ chelates to Gd-nanoparticles. Eur. J. Inorg. Chem. 2012, 2012, 1924–1933.
43. Bui, T.; Stevenson, J.; Hoekman, J.; Zhang, S.; Maravilla, K.; Ho, R.J. Novel gd nanoparticles enhance vascular contrast for high-resolution magnetic resonance imaging. PLoS ONE 2010, 5, e13082.
44. 18F-FDG using a combined PET/MR scanner. Atherosclerosis 2013, 228, 339–345.
45. Uppal, R.; Ay, I.; Dai, G.; Kim, Y.R.; Sorensen, A.G.; Caravan, P. Molecular mri of intracranial thrombus in a rat ischemic stroke model. Stroke J. Cereb. Circ. 2010, 41, 1271–1277.
46. Klink, A.; Heynens, J.; Herranz, B.; Lobatto, M.E.; Arias, T.; Sanders, H.M.; Strijkers, G.J.; Merkx, M.; Nicolay, K.; Fuster, V.; et al. In vivo characterization of a new abdominal aortic aneurysm mouse model with conventional and molecular magnetic resonance imaging. J. Am. Coll. Cardiol. 2011, 58, 2522–2530.
47. Botnar, R.M.; Wiethoff, A.J.; Ebersberger, U.; Lacerda, S.; Blume, U.; Warley, A.; Jansen, C.H.; Onthank, D.C.; Cesati, R.R.; Razavi, R.; et al. In vivo assessment of aortic aneurysm wall integrity using elastin-specific molecular magnetic resonance imaging. Circ. Cardiovasc. Imag. 2014, 7, 679–689.
48. Joshi, R.; Yanasak, N. Magnetic resonance angiography study of a normal mouse brain for creating a three-dimensional cerebral vasculature atlas and software for labeling vessels. In Proceedings of the 2011 IEEE International Conference on Bioinformatics and Biomedicine Workshops (BIBMW), Atlanta, GA, USA, 12–15 November, 2011; pp. 966–968.
49. Klohs, J.; Baltes, C.; Princz-Kranz, F.; Ratering, D.; Nitsch, R.M.; Knuesel, I.; Rudin, M. Contrast-enhanced magnetic resonance microangiography reveals remodeling of the cerebral microvasculature in transgenic arcabeta mice. J. Neurosci. Off. J. Soc. Neurosci. 2012, 32, 1705–1713.
50. Goergen, C.J.; Azuma, J.; Barr, K.N.; Magdefessel, L.; Kallop, D.Y.; Gogineni, A.; Grewall, A.; Weimer, R.M.; Connolly, A.J.; Dalman, R.L.; et al. Influences of aortic motion and curvature on vessel expansion in murine experimental aneurysms. Arterioscler. Thromb. Vasc. Biol. 2011, 31, 270–279.
51. Greve, J.M.; Les, A.S.; Tang, B.T.; Draney Blomme, M.T.; Wilson, N.M.; Dalman, R.L.; Pelc, N.J.; Taylor, C.A. Allometric scaling of wall shear stress from mice to humans: Quantification using cine phase-contrast mri and computational fluid dynamics. Am. J. Physiol. Heart Circ. Physiol. 2006, 291, H1700–H1708.
52. Pieles, G.E.; Szantho, G.; Rodrigues, J.C.; Lawton, C.B.; Stuart, A.G.; Bucciarelli-Ducci, C.; Turner, M.S.; Williams, C.A.; Tulloh, R.M.; Hamilton, M.C. Adaptations of aortic and pulmonary artery flow parameters measured by phase-contrast magnetic resonance angiography during supine aerobic exercise. Eur. J. Appl. Physiol. 2014, 114, 1013–1023.
53. Muir, E.R.; Watts, L.T.; Tiwari, Y.V.; Bresnen, A.; Shen, Q.; Duong, T.Q. Quantitative cerebral blood flow measurements using mri. Methods Mol. Biol. 2014, 1135, 205–211.
54. Klink, A.; Hyafil, F.; Rudd, J.; Faries, P.; Fuster, V.; Mallat, Z.; Meilhac, O.; Mulder, W.J.; Michel, J.B.; Ramirez, F.; et al. Diagnostic and therapeutic strategies for small abdominal aortic aneurysms. Nat. Rev. Cardiol. 2011, 8, 338–347.
55. Ogawa, S.; Lee, T.-M.; Kay, A.R.; Tank, D.W. Brain magnetic resonance imaging with contrast dependent on blood oxygenation. Proc. Natl. Acad. Sci. USA 1990, 87, 9868–9872.
56. Greve, J.M.; Williams, S.P.; Bernstein, L.J.; Goldman, H.; Peale, F.V.; Bunting, S.; van Bruggen, N. Reactive hyperemia and BOLD MRI demonstrate that VEGF inhibition, age, and atherosclerosis adversely affect functional recovery in a murine model of peripheral artery disease. J. Magn. Reson. Imaging 2008, 28, 996–1004.
57. Kwong, R.Y.; Yucel, E.K. Cardiology patient pages. Computed tomography scan and magnetic resonance imaging. Circulation 2003, 108, e104–e106.
58. Pichler, B.J.; Judenhofer, M.S.; Pfannenberg, C. Multimodal imaging approaches: PET/CT and PET/MRI. Handb. Exp. Pharmacol. 2008, 109–132. doi:10.1007/978-3-540-72718-7_6.
59. Tirziu, D.; Moodie, K.L.; Zhuang, Z.W.; Singer, K.; Helisch, A.; Dunn, J.F.; Li, W.; Singh, J.; Simons, M. Delayed arteriogenesis in hypercholesterolemic mice. Circulation 2005, 112, 2501–2509.
60. Morgan, M.K.; Anderson, R.E.; Sundt, T.M., Jr. A model of the pathophysiology of cerebral arteriovenous malformations by a carotid-jugular fistula in the rat. Brain Res. 1989, 496, 241–250.
61. Abruzzo, T.; Tumialan, L.; Chaalala, C.; Kim, S.; Guldberg, R.E.; Lin, A.; Leach, J.; Khoury, J.C.; Morgan, A.E.; Cawley, C.M., 3rd. Microscopic computed tomography imaging of the cerebral circulation in mice: Feasibility and pitfalls. Synapse 2008, 62, 557–565.
62. Yao, Y.; Jumabay, M.; Wang, A.; Bostrom, K.I. Matrix Gla protein deficiency causes arteriovenous malformations in mice. J. Clin. Investig. 2011, 121, 2993–3004.
63. Schambach, S.J.; Bag, S.; Schilling, L.; Groden, C.; Brockmann, M.A. Application of micro-CT in small animal imaging. Methods 2010, 50, 2–13.
64. Vandeghinste, B.; Trachet, B.; Renard, M.; Casteleyn, C.; Staelens, S.; Loeys, B.; Segers, P.; Vandenberghe, S. Replacing vascular corrosion casting by in vivo micro-CT imaging for building 3D cardiovascular models in mice. Mol. Imaging Biol. 2011, 13, 78–86.
65. Staub, D.; Partovi, S.; Imfeld, S.; Uthoff, H.; Baldi, T.; Aschwanden, M.; Jaeger, K. Novel applications of contrast-enhanced ultrasound imaging in vascular medicine. VASA. Z. Gefasskrankh. 2013, 42, 17–31.
66. Shim, C.Y.; Lindner, J.R. Cardiovascular molecular imaging with contrast ultrasound: Principles and applications. Korean Circ. J. 2014, 44, 1–9.
67. Bondke, A.; Hillmeister, P.; Buschmann, I.R. Exact assessment of perfusion and collateral vessel proliferation in small animal models. Circ. Res. 2007, 100, e82–e83.
68. Chin, M.S.; Freniere, B.B.; Lo, Y.-C.; Saleeby, J.H.; Baker, S.P.; Strom, H.M.; Ignotz, R.A.; Lalikos, J.F.; Fitzgerald, T.J. Hyperspectral imaging for early detection of oxygenation and perfusion changes in irradiated skin. J. Biomed. Opt. 2012, 17, 0260101–0260105.
69. Yudovsky, D.; Nouvong, A.; Pilon, L. Hyperspectral imaging in diabetic foot wound care. J. Diabetes Sci. Technol. 2010, 4, 1099–1113.
70. Frangioni, J.V. In vivo near-infrared fluorescence imaging. Curr. Opin. Chem. Biol. 2003, 7, 626–634.
71. Kim, J.; Herrero, P.; Sharp, T.; Laforest, R.; Rowland, D.J.; Tai, Y.C.; Lewis, J.S.; Welch, M.J. Minimally invasive method of determining blood input function from pet images in rodents. J. Nucl. Med. 2006, 47, 330–336.
72. Yoo, H.; Kim, J.W.; Shishkov, M.; Namati, E.; Morse, T.; Shubochkin, R.; McCarthy, J.R.; Ntziachristos, V.; Bouma, B.E.; Jaffer, F.A.; et al. Intra-arterial catheter for simultaneous microstructural and molecular imaging in vivo. Nat. Med. 2011, 17, 1680–1684.
73. Li, X.; Li, J.; Jing, J.; Ma, T.; Liang, S.; Zhang, J.; Mohar, D.; Raney, A.; Mahon, S.; Brenner, M.; et al. Integrated ivus-oct imaging for atherosclerotic plaque characterization. IEEE J. Sel. Top. Quantum Electron. 2014, 20, doi:10.1109/JSTQE.2013.2274724.
74. Wang, P.; Ma, T.; Slipchenko, M.N.; Liang, S.; Hui, J.; Shung, K.K.; Roy, S.; Sturek, M.; Zhou, Q.; Chen, Z.; et al. High-speed intravascular photoacoustic imaging of lipid-laden atherosclerotic plaque enabled by a 2-kHz barium nitrite raman laser. Sci. Rep. 2014, 4, doi:10.1038/srep06889.
75. Tropea, B.I.; Schwarzacher, S.P.; Chang, A.; Asvar, C.; Huie, P.; Sibley, R.K.; Zarins, C.K. Reduction of aortic wall motion inhibits hypertension-mediated experimental atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 2000, 20, 2127–2133.
76. Wilson, J.S.; Virag, L.; Di Achille, P.; Karsaj, I.; Humphrey, J.D. Biochemomechanics of intraluminal thrombus in abdominal aortic aneurysms. J. Biomech. Eng. 2013, 135, doi:10.1115/1.4023437.
77. Markl, M.; Wu, C.; Hurley, M.C.; Ansari, S.A.; Carroll, T.J.; Rahme, R.J.; Aoun, S.G.; Carr, J.; Batjer, H.; Bendok, B.R. Cerebral arteriovenous malformation: Complex 3D hemodynamics and 3D blood flow alterations during staged embolization. J. Magn. Reson. Imaging 2013, 38, 946–950.
78. Raut, S.S.; Chandra, S.; Shum, J.; Finol, E.A. The role of geometric and biomechanical factors in abdominal aortic aneurysm rupture risk assessment. Ann. Biomed. Eng. 2013, 41, 1459–1477.
79. Willmann, J.K.; Chen, K.; Wang, H.; Paulmurugan, R.; Rollins, M.; Cai, W.; Wang, D.S.; Chen, I.Y.; Gheysens, O.; Rodriguez-Porcel, M.; et al. Monitoring of the biological response to murine hindlimb ischemia with 64Cu-labeled vascular endothelial growth factor-121 positron emission tomography. Circulation 2008, 117, 915–922.
80. Makowski, M.R.; Preissel, A.; von Bary, C.; Warley, A.; Schachoff, S.; Keithan, A.; Cesati, R.R.; Onthank, D.C.; Schwaiger, M.; Robinson, S.P.; et al. Three-dimensional imaging of the aortic vessel wall using an elastin-specific magnetic resonance contrast agent. Investig. Radiol. 2012, 47, 438–444.
81. Starmans, L.W.; van Duijnhoven, S.M.; Rossin, R.; Aime, S.; Daemen, M.J.; Nicolay, K.; Grull, H. Spect imaging of fibrin using fibrin-binding peptides. Contrast Media Mol. Imaging 2013, 8, 229–237.
82. Maegdefessel, L.; Dalman, R.L.; Tsao, P.S. Pathogenesis of abdominal aortic aneurysms: Micrornas, proteases, genetic associations. Annu. Rev. Med. 2014, 65, 49–62.
83. Daugherty, A.; Cassis, L.A. Mouse models of abdominal aortic aneurysms. Arterioscler. Thromb. Vasc. Biol. 2004, 24, 429–434.
84. Steinberg, D. The LDL modification hypothesis of atherogenesis: An update. J. Lipid Res. 2009, 50, S376–S381.
85. Chiou, A.C.; Chiu, B.; Pearce, W.H. Murine aortic aneurysm produced by periarterial application of calcium chloride. J. Surg. Res. 2001, 99, 371–376.
86. Anidjar, S.; Salzmann, J.L.; Gentric, D.; Lagneau, P.; Camilleri, J.P.; Michel, J.B. Elastase-induced experimental aneurysms in rats. Circulation 1990, 82, 973–981.
87. Wang, Y.; Krishna, S.; Golledge, J. The calcium chloride-induced rodent model of abdominal aortic aneurysm. Atherosclerosis 2013, 226, 29–39.
88. Pyo, R.; Lee, J.K.; Shipley, J.M.; Curci, J.A.; Mao, D.; Ziporin, S.J.; Ennis, T.L.; Shapiro, S.D.; Senior, R.M.; Thompson, R.W. Targeted gene disruption of matrix metalloproteinase-9 (gelatinase B) suppresses development of experimental abdominal aortic aneurysms. J. Clin. Investig. 2000, 105, 1641–1649.
89. Carsten, C.G., 3rd; Calton, W.C.; Johanning, J.M.; Armstrong, P.J.; Franklin, D.P.; Carey, D.J.; Elmore, J.R. Elastase is not sufficient to induce experimental abdominal aortic aneurysms. J. Vasc. Surg. 2001, 33, 1255–1262.
90. Bhamidipati, C.M.; Mehta, G.S.; Lu, G.Y.; Moehle, C.W.; Barbery, C.; DiMusto, P.D.; Laser, A.; Kron, I.L.; Upchurch, G.R.; Ailawadi, G. Development of a novel murine model of aortic aneurysms using peri-adventitial elastase. Surgery 2012, 152, 238–246.
91. Plump, A.S.; Smith, J.D.; Hayek, T.; Aalto-Setala, K.; Walsh, A.; Verstuyft, J.G.; Rubin, E.M.; Breslow, J.L. Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in es cells. Cell 1992, 71, 343–353.
92. Zhang, S.H.; Reddick, R.L.; Piedrahita, J.A.; Maeda, N. Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein e. Science 1992, 258, 468–471.
93. Daugherty, A.; Cassis, L. Chronic angiotensin II infusion promotes atherogenesis in low density lipoprotein receptor −/− mice. Ann. N. Y. Acad. Sci. 1999, 892, 108–118.
94. Meir, K.S.; Leitersdorf, E. Atherosclerosis in the apolipoprotein-e-deficient mouse: A decade of progress. Arterioscler. Thromb. Vasc. Biol. 2004, 24, 1006–1014.
95. Upmacis, R.K.; Crabtree, M.J.; Deeb, R.S.; Shen, H.; Lane, P.B.; Benguigui, L.E.; Maeda, N.; Hajjar, D.P.; Gross, S.S. Profound biopterin oxidation and protein tyrosine nitration in tissues of apoe-null mice on an atherogenic diet: Contribution of inducible nitric oxide synthase. Am. J. Physiol. Heart Circ. Physiol. 2007, 293, H2878–H2887.
96. Daugherty, A.; Manning, M.W.; Cassis, L.A. Angiotensin ii promotes atherosclerotic lesions and aneurysms in apolipoprotein e-deficient mice. J. Clin. Investig. 2000, 105, 1605–1612.
97. Saraff, K.; Babamusta, F.; Cassis, L.A.; Daugherty, A. Aortic dissection precedes formation of aneurysms and atherosclerosis in angiotensin II-infused, apolipoprotein E-deficient mice. Arterioscler. Thromb. Vasic. 2003, 23, 1621–1626.
98. Davis, F.M.; Rateri, D.L.; Balakrishnan, A.; Howatt, D.A.; Strickland, D.K.; Muratoglu, S.C.; Haggerty, C.M.; Fornwalt, B.K.; Cassis, L.A.; Daugherty, A. Smooth muscle cell deletion of low-density lipoprotein receptor-related protein 1 augments angiotensin II-induced superior mesenteric arterial and ascending aortic aneurysms. Arterioscler. Thromb. Vasc. Biol. 2015, 35, 155–162.
99. Kaijzel, E.L.; van Heijningen, P.M.; Wielopolski, P.A.; Vermeij, M.; Koning, G.A.; van Cappellen, W.A.; Que, I.; Chan, A.; Dijkstra, J.; Ramnath, N.W.; et al. Multimodality imaging reveals a gradual increase in matrix metalloproteinase activity at aneurysmal lesions in live fibulin-4 mice. Circ. Cardiovasc. Imaging 2010, 3, 567–577.
100. Ramaswamy, A.K.; Hamilton, M.; Joshi, R.V.; Kline, B.P.; Li, R.; Wang, P.; Goergen, C.J. Molecular imaging of experimental abdominal aortic aneurysms. Sci. World J. 2013, 2013, doi:10.1155/2013/973150.
101. Golledge, J.; Norman, P.E. Atherosclerosis and abdominal aortic aneurysm: Cause, response, or common risk factors? Arterioscler. Thromb. Vasc. Biol. 2010, 30, 1075–1077.
102. Hirsch, A.T.; Haskal, Z.J.; Hertzer, N.R.; Bakal, C.W.; Creager, M.A.; Halperin, J.L.; Hiratzka, L.F.; Murphy, W.R.; Olin, J.W.; Puschett, J.B.; et al. ACC/AHA 2005 practice guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): A collaborative report from the american association for vascular surgery/society for vascular surgery, society for cardiovascular angiography and interventions, society for vascular medicine and biology, society of interventional radiology, and the acc/aha task force on practice guidelines (writing committee to develop guidelines for the management of patients with peripheral arterial disease): Endorsed by the american association of cardiovascular and pulmonary rehabilitation; national heart, lung, and blood institute; society for vascular nursing; transatlantic inter-society consensus; and vascular disease foundation. Circulation 2006, 113, e463–e654.
103. Lederle, F.A.; Wilson, S.E.; Johnson, G.R.; Reinke, D.B.; Littooy, F.N.; Acher, C.W.; Messina, L.M.; Ballard, D.J.; Ansel, H.J. Variability in measurement of abdominal aortic aneurysms. Abdominal aortic aneurysm detection and management veterans administration cooperative study group. J. Vasc. Surg. 1995, 21, 945–952.
104. Sprouse, L.R.; Meier, G.H.; Parent, F.N.; DeMasi, R.J.; Glickman, M.H.; Barber, G.A. Is ultrasound more accurate than axial computed tomography for determination of maximal abdominal aortic aneurysm diameter? Eur. J. Vasc. Endovasc. Surg. 2004, 28, 28–35.
105. Jaakkola, P.; Hippelainen, M.; Farin, P.; Rytkonen, H.; Kainulainen, S.; Partanen, K. Interobserver variability in measuring the dimensions of the abdominal aorta: Comparison of ultrasound and computed tomography. Eur. J. Vasc. Endovasc. Surg. 1996, 12, 230–237.
106. Moxon, J.V.; Parr, A.; Emeto, T.I.; Walker, P.; Norman, P.E.; Golledge, J. Diagnosis and monitoring of abdominal aortic aneurysm: Current status and future prospects. Curr. Probl. Cardiol. 2010, 35, 512–548.
107. Turner, G.H.; Olzinski, A.R.; Bernard, R.E.; Aravindhan, K.; Karr, H.W.; Mirabile, R.C.; Willette, R.N.; Gough, P.J.; Jucker, B.M. In vivo serial assessment of aortic aneurysm formation in apolipoprotein E-deficient mice via MRI. Circ. Cardiovasc. Imaging 2008, 1, 220–226.
108. Goergen, C.J.; Barr, K.N.; Huynh, D.T.; Eastham-Anderson, J.R.; Choi, G.; Hedehus, M.; Dalman, R.L.; Connolly, A.J.; Taylor, C.A.; Tsao, P.S.; et al. In vivo quantification of murine aortic cyclic strain, motion, and curvature: Implications for abdominal aortic aneurysm growth. J. Magn. Reson. Imaging JMRI 2010, 32, 847–858.
109. −/− mice. Ann. Biomed. Eng. 2011, 39, 2430–2444.
110. Goergen, C.J.; Johnson, B.L.; Greve, J.M.; Taylor, C.A.; Zarins, C.K. Increased anterior abdominal aortic wall motion: Possible role in aneurysm pathogenesis and design of endovascular devices. J. Endovasc. Ther. 2007, 14, 574–584.
111. Favreau, J.T.; Nguyen, B.T.; Gao, I.; Yu, P.; Tao, M.; Schneiderman, J.; Gaudette, G.R.; Ozaki, C.K. Murine ultrasound imaging for circumferential strain analyses in the angiotensin II abdominal aortic aneurysm model. J. Vasc. Surg. 2012, 56, 462–469.
112. −/− rodent models of abdominal aortic aneurysms. BioMed. Res. Int. 2015, in press.
113. Luo, J.; Konofagou, E.E. Imaging of wall motion coupled with blood flow velocity in the heart and vessels in vivo: A feasibility study. Ultrasound Med. Biol. 2011, 37, 980–995.
114. Humphrey, J.D.; Taylor, C.A. Intracranial and abdominal aortic aneurysms: Similarities, differences, and need for a new class of computational models. Annu. Rev. Biomed. Eng. 2008, 10, 221–246.
115. Bersi, M.R.; Collins, M.J.; Wilson, E.; Humphrey, J.D. Disparate changes in the mechanical properties of murine carotid arteries and aorta in response to chronic infusion of angiotensin-II. Int. J. Adv. Eng. Sci. Appl. Math. 2013, 4, 228–240.
116. Trachet, B.; Bols, J.; de Santis, G.; Vandenberghe, S.; Loeys, B.; Segers, P. The impact of simplified boundary conditions and aortic arch inclusion on CFD simulations in the mouse aorta: A comparison with mouse-specific reference data. J. Biomech. Eng. 2011, 133, doi:10.1115/1.4005479.
117. Assemat, P.; Siu, K.K.; Armitage, J.A.; Hokke, S.N.; Dart, A.; Chin-Dusting, J.; Hourigan, K. Haemodynamical stress in mouse aortic arch with atherosclerotic plaques: Preliminary study of plaque progression. Comput. Struct. Biotechnol. J. 2014, 10, 98–106.
118. Cao, R.Y.; Amand, T.; Ford, M.D.; Piomelli, U.; Funk, C.D. The murine angiotensin II-induced abdominal aortic aneurysm model: Rupture risk and inflammatory progression patterns. Front. Pharmacol. 2010, 1, doi:10.3389/fphar.2010.00009.
119. Ford, M.D.; Black, A.T.; Cao, R.Y.; Funk, C.D.; Piomelli, U. Hemodynamics of the mouse abdominal aortic aneurysm. J. Biomech. Eng. 2011, 133, doi:10.1115/1.4005477.
120. Truijers, M.; Kurvers, H.A.; Bredie, S.J.; Oyen, W.J.; Blankensteijn, J.D. In vivo imaging of abdominal aortic aneurysms: Increased FDG uptake suggests inflammation in the aneurysm wall. J. Endovasc. Ther. 2008, 15, 462–467.
121. 18 F-FDG uptake assessed by PET/CT in abdominal aortic aneurysms is associated with cellular and molecular alterations prefacing wall deterioration and rupture. J. Nucl. Med. 2013, 54, 1740–1747.
122. Reeps, C.; Bundschuh, R.A.; Pellisek, J.; Herz, M.; van Marwick, S.; Schwaiger, M.; Eckstein, H.H.; Nekolla, S.G.; Essler, M. Quantitative assessment of glucose metabolism in the vessel wall of abdominal aortic aneurysms: Correlation with histology and role of partial volume correction. Int. J. Cardiovasc. Imaging 2013, 29, 505–512.
123. Sheikine, Y.; Akram, K. FDG-PET imaging of atherosclerosis: Do we know what we see? Atherosclerosis 2010, 211, 371–380.
124. 18 F-FDG aortic aneurysm uptake on pet/ct and future growth rate? Eur. J. Nucl. Med. Mol. Imaging 2011, 38, 1493–1499.
125. Palombo, D.; Morbelli, S.; Spinella, G.; Pane, B.; Marini, C.; Rousas, N.; Massollo, M.; Cittadini, G.; Camellino, D.; Sambuceti, G. A positron emission tomography/computed tomography (PET/CT) evaluation of asymptomatic abdominal aortic aneurysms: Another point of view. Ann. Vasc. Surg. 2012, 26, 491–499.
126. 18 F-FDG uptake is predictive of rupture in a novel rat abdominal aortic aneurysm rupture model. Ann. Surg. 2015, 261, 395–404.
127. Wang, Y.; Ait-Oufella, H.; Herbin, O.; Bonnin, P.; Ramkhelawon, B.; Taleb, S.; Huang, J.; Offenstadt, G.; Combadiere, C.; Renia, L.; et al. TGF-β activity protects against inflammatory aortic aneurysm progression and complications in angiotensin II-infused mice. J. Clin. Investig. 2010, 120, 422–432.
128. Sarda-Mantel, L.; Coutard, M.; Rouzet, F.; Raguin, O.; Vrigneaud, J.M.; Hervatin, F.; Martet, G.; Touat, Z.; Merlet, P.; Le Guludec, D.; et al. 99m Tc-annexin-V functional imaging of luminal thrombus activity in abdominal aortic aneurysms. Arterioscler. Thromb. Vasc. Biol. 2006, 26, 2153–2159.
129. 18 F-labeled Arg-Gly-Asp positron-emission tomography. Circ. Cardiovasc. Imaging 2013, 6, 950–956.
130. Nahrendorf, M.; Keliher, E.; Marinelli, B.; Leuschner, F.; Robbins, C.S.; Gerszten, R.E.; Pittet, M.J.; Swirski, F.K.; Weissleder, R. Detection of macrophages in aortic aneurysms by nanoparticle positron emission tomography-computed tomography. Arterioscler. Thromb. Vasc. Biol. 2011, 31, 750–757.
131. Sheth, R.A.; Maricevich, M.; Mahmood, U. In vivo optical molecular imaging of matrix metalloproteinase activity in abdominal aortic aneurysms correlates with treatment effects on growth rate. Atherosclerosis 2010, 212, 181–187.
132. −/− mice by uspio-enhanced magnetic resonance imaging. Investig. Radiol. 2010, 45, 702–707.
133. Hyafil, F.; Vucic, E.; Cornily, J.C.; Sharma, R.; Amirbekian, V.; Blackwell, F.; Lancelot, E.; Corot, C.; Fuster, V.; Galis, Z.S.; et al. Monitoring of arterial wall remodelling in atherosclerotic rabbits with a magnetic resonance imaging contrast agent binding to matrix metalloproteinases. Eur. Heart J. 2011, 32, 1561–1571.
134. Lu, Y.; Wei, J.; Shao, Q.; Tang, Y.; Huang, Y.; Zhang, H.; Yang, W.; Jing, Z. Assessment of atherosclerotic plaques in the rabbit abdominal aorta with interleukin-8 monoclonal antibody-targeted ultrasound microbubbles. Mol. Biol. Rep. 2013, 40, 3083–3092.
135. Kee, P.; Bagalkot, V.; Johnson, E.; Danila, D. Noninvasive detection of macrophages in atheroma using a radiocontrast-loaded phosphatidylserine-containing liposomal contrast agent for computed tomography. Mol. Imaging Biol. 2014, in press.
136. Lobatto, M.E.; Calcagno, C.; Millon, A.; Senders, M.L.; Fay, F.; Robson, P.M.; Ramachandran, S.; Binderup, T.; Paridaans, M.P.; Sensarn, S.; et al. Atherosclerotic plaque targeting mechanism of long-circulating nanoparticles established by multimodal imaging. ACS Nano 2015, 24, 1837–1847.
137. 18 F-fluoromisonidazole positron emission tomographic imaging. Circ. Cardiovasc. Imaging 2014, 7, 312–320.
138. Ohshima, S.; Petrov, A.; Fujimoto, S.; Zhou, J.; Azure, M.; Edwards, D.S.; Murohara, T.; Narula, N.; Tsimikas, S.; Narula, J. Molecular imaging of matrix metalloproteinase expression in atherosclerotic plaques of mice deficient in apolipoprotein e or low-density-lipoprotein receptor. J. Nucl. Med. 2009, 50, 612–617.
139. Phinikaridou, A.; Andia, M.E.; Indermuehle, A.; Onthank, D.C.; Cesati, R.R.; Smith, A.; Robinson, S.P.; Saha, P.; Botnar, R.M. Vascular remodeling and plaque vulnerability in a rabbit model of atherosclerosis: Comparison of delayed-enhancement mr imaging with an elastin-specific contrast agent and unenhanced black-blood MR imaging. Radiology 2014, 271, 390–399.
140. Maegdefessel, L.; Azuma, J.; Toh, R.; Merk, D.R.; Deng, A.; Chin, J.T.; Raaz, U.; Schoelmerich, A.M.; Raiesdana, A.; Leeper, N.J.; et al. Inhibition of microRNA-29b reduces murine abdominal aortic aneurysm development. J. Clin. Investig. 2012, 122, 497–506.
141. Pantoni, L. Cerebral small vessel disease: From pathogenesis and clinical characteristics to therapeutic challenges. Lancet Neurol. 2010, 9, 689–701.
142. Westrick, R.J.; Winn, M.E.; Eitzman, D.T. Murine models of vascular thrombosis (eitzman series). Arterioscler. Thromb. Vasc. Biol. 2007, 27, 2079–2093.
143. Kurz, K.D.; Main, B.W.; Sandusky, G.E. Rat model of arterial thrombosis induced by ferric chloride. Thromb. Res. 1990, 60, 269–280.
144. Kusada, A.; Isogai, N.; Cooley, B.C. Electric injury model of murine arterial thrombosis. Thromb. Res. 2007, 121, 103–106.
145. Yeh, J.C.; Huang, K.L.; Hsiao, Y.C.; Hsu, Y.H.; Lin, Y.H.; Lou, S.L.; Lee, T.H. A rat model of thrombosis in common carotid artery induced by implantable wireless light-emitting diode device. BioMed. Res. Int. 2014, 2014, doi:10.1155/2014/724134.
146. Longa, E.Z.; Weinstein, P.R.; Carlson, S.; Cummins, R. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke J. Cereb. Circ. 1989, 20, 84–91.
147. Koizumi, J.; Yoshida, Y.; Nakazawa, T.; Ooneda, G. Experimental studies of ischemic brain edema, I: A new experimental model of cerebral embolism in rats in which recirculation can be introduced in the ischemic area. Jpn. J. Stroke 1986, 8, 1–8.
148. Schunke, K.J.; Toung, T.K.; Zhang, J.; Pathak, A.P.; Xu, J.; Zhang, J.; Koehler, R.C.; Faraday, N. A novel atherothrombotic model of ischemic stroke induced by injection of collagen into the cerebral vasculature. J. Neurosci. Methods 2015, 239, 65–74.
149. De Lange, F.; Dieleman, J.M.; Blezer, E.L.; Houston, R.J.; Kalkman, C.J.; Nijsen, J.F. Unilateral intracarotid injection of holmium microspheres to induce bilateral MRI-validated cerebral embolization in rats. J. Neurosci. Methods 2009, 176, 152–156.
150. Hattori, Y.; Kitamura, A.; Nagatsuka, K.; Ihara, M. A novel mouse model of ischemic carotid artery disease. PLoS ONE 2014, 9, e100257.
151. Tao, M.; Mauro, C.R.; Yu, P.; Favreau, J.T.; Nguyen, B.; Gaudette, G.R.; Ozaki, C.K. A simplified murine intimal hyperplasia model founded on a focal carotid stenosis. Am. J. Pathol. 2013, 182, 277–287.
152. Hilger, T.; Niessen, F.; Diedenhofen, M.; Hossmann, K.A.; Hoehn, M. Magnetic resonance angiography of thromboembolic stroke in rats: Indicator of recanalization probability and tissue survival after recombinant tissue plasminogen activator treatment. J. Cereb. Blood Flow Metab. 2002, 22, 652–662.
153. Li, Y.; Baran, U.; Wang, R.K. Application of thinned-skull cranial window to mouse cerebral blood flow imaging using optical microangiography. PLoS ONE 2014, 9, e113658.
154. Chen, C.-Y.; Menon, P.; Kowalski, W.; Pekkan, K. Time-resolved oct-μpiv: A new microscopic piv technique for noninvasive depth-resolved pulsatile flow profile acquisition. Exp. Fluids 2012, 54, 1–9.
155. Lam, C.K.; Yoo, T.; Hiner, B.; Liu, Z.; Grutzendler, J. Embolus extravasation is an alternative mechanism for cerebral microvascular recanalization. Nature 2010, 465, 478–482.
156. Yeom, E.; Nam, K.H.; Jin, C.; Paeng, D.G.; Lee, S.J. 3D reconstruction of a carotid bifurcation from 2D transversal ultrasound images. Ultrasonics 2014, 54, 2184–2192.
157. Wu, J.; Zhang, H.; Zheng, H.; Jiang, Y. Hepatic inflammation scores correlate with common carotid intima-media thickness in rats with nafld induced by a high-fat diet. BMC Vet. Res. 2014, 10, doi:10.1186/1746-6148-10-162.
158. Starmans, L.W.; van Duijnhoven, S.M.; Rossin, R.; Berben, M.; Aime, S.; Daemen, M.J.; Nicolay, K.; Grull, H. Evaluation of 111in-labeled epep and fibpep as tracers for fibrin spect imaging. Mol. Pharm. 2013, 10, 4309–4321.
159. Wenning, C.; Kloth, C.; Kuhlmann, M.T.; Jacobs, A.H.; Schober, O.; Hermann, S.; Schafers, M.A. Serial F-18-Fdg PET/CT distinguishes inflamed from stable plaque phenotypes in shear-stress induced murine atherosclerosis. Atherosclerosis 2014, 234, 276–282.
160. Keedy, A. An overview of intracranial aneurysms. McGill J. Med. 2006, 9, 141–146.
161. Foutrakis, G.N.; Yonas, H.; Sclabassi, R.J. Saccular aneurysm formation in curved and bifurcating arteries. Am. J. Neuroradiol. 1999, 20, 1309–1317.
162. Wang, Y.; Emeto, T.I.; Lee, J.; Marshman, L.; Moran, C.; Seto, S.W.; Golledge, J. Mouse models of intracranial aneurysm. Brain Pathol. 2014, doi:10.1111/bpa.12175.
163. Short, J.G.; Fujiwara, N.H.; Marx, W.F.; Helm, G.A.; Cloft, H.J.; Kallmes, D.F. Elastase-induced saccular aneurysms in rabbits: Comparison of geometric features with those of human aneurysms. Am. J. Neuroradiol. 2001, 22, 1833–1837.
164. Kondo, S.; Hashimoto, N.; Kikuchi, H.; Hazama, F.; Nagata, I.; Kataoka, H. Apoptosis of medial smooth muscle cells in the development of saccular cerebral aneurysms in rats. Stroke J. Cereb. Circ. 1998, 29, 181–188.
165. Nagata, I.; Handa, H.; Hashimoto, N.; Hazama, F. Experimentally induced cerebral aneurysms in rats: Part VI. Hypertension. Surg. Neurol. 1980, 14, 477–479.
166. Kirse, D.J.; Flock, S.; Teo, C.; Rahman, S.; Mrak, R. Construction of a vein-pouch aneurysm at a surgically created carotid bifurcation in the rat. Microsurgery 1996, 17, 681–689.
167. Bouzeghrane, F.; Naggara, O.; Kallmes, D.F.; Berenstein, A.; Raymond, J.; International Consortium of Neuroendovascular, C. In vivo experimental intracranial aneurysm models: A systematic review. AJNR. Am. J. Neuroradiol. 2010, 31, 418–423.
168. Verma, R.K.; Kottke, R.; Andereggen, L.; Weisstanner, C.; Zubler, C.; Gralla, J.; Kiefer, C.; Slotboom, J.; Wiest, R.; Schroth, G.; et al. Detecting subarachnoid hemorrhage: Comparison of combined flair/swi versus ct. Eur. J. Radiol. 2013, 82, 1539–1545.
169. Busch, E.; Beaulieu, C.; de Crespigny, A.; Moseley, M.E. Diffusion mr imaging during acute subarachnoid hemorrhage in rats. Stroke J. Cereb. Circ. 1998, 29, 2155–2161.
170. McCormick, P.W.; McCormick, J.; Zabramski, J.M.; Spetzler, R.F. Hemodynamics of subarachnoid hemorrhage arrest. J. Neurosurg. 1994, 80, 710–715.
171. Stapf, C.; Mohr, J.P.; Choi, J.H.; Hartmann, A.; Mast, H. Invasive treatment of unruptured brain arteriovenous malformations is experimental therapy. Curr. Opin. Neurol. 2006, 19, 63–68.
172. Srinivasan, S.; Hanes, M.A.; Dickens, T.; Porteous, M.E.; Oh, S.P.; Hale, L.P.; Marchuk, D.A. A mouse model for hereditary hemorrhagic telangiectasia (HHT) type 2. Hum. Mol. Genet. 2003, 12, 473–482.
173. Xu, B.; Wu, Y.Q.; Huey, M.; Arthur, H.M.; Marchuk, D.A.; Hashimoto, T.; Young, W.L.; Yang, G.Y. Vascular endothelial growth factor induces abnormal microvasculature in the endoglin heterozygous mouse brain. J. Cereb. Blood Flow Metab. 2004, 24, 237–244.
174. Walker, E.J.; Su, H.; Shen, F.; Choi, E.J.; Oh, S.P.; Chen, G.; Lawton, M.T.; Kim, H.; Chen, Y.; Chen, W.; et al. Arteriovenous malformation in the adult mouse brain resembling the human disease. Ann. Neurol. 2011, 69, 954–962.
175. Satomi, J.; Mount, R.J.; Toporsian, M.; Paterson, A.D.; Wallace, M.C.; Harrison, R.V.; Letarte, M. Cerebral vascular abnormalities in a murine model of hereditary hemorrhagic telangiectasia. Stroke J. Cereb. Circ. 2003, 34, 783–789.
176. Milton, I.; Ouyang, D.; Allen, C.J.; Yanasak, N.E.; Gossage, J.R.; Alleyne, C.H., Jr.; Seki, T. Age-dependent lethality in novel transgenic mouse models of central nervous system arteriovenous malformations. StrokeJ. Cereb. Circ. 2012, 43, 1432–1435.
177. Choi, E.J.; Chen, W.; Jun, K.; Arthur, H.M.; Young, W.L.; Su, H. Novel brain arteriovenous malformation mouse models for type 1 hereditary hemorrhagic telangiectasia. PLoS ONE 2014, 9, e88511.
178. Park, S.O.; Wankhede, M.; Lee, Y.J.; Choi, E.J.; Fliess, N.; Choe, S.W.; Oh, S.H.; Walter, G.; Raizada, M.K.; Sorg, B.S.; et al. Real-time imaging of de novo arteriovenous malformation in a mouse model of hereditary hemorrhagic telangiectasia. J. Clin. Investig. 2009, 119, 3487–3496.
179. Murphy, P.A.; Kim, T.N.; Lu, G.; Bollen, A.W.; Schaffer, C.B.; Wang, R.A. Notch4 normalization reduces blood vessel size in arteriovenous malformations. Sci. Transl. Med. 2012, 4, doi:10.1126/scitranslmed.3002670.
180. Murphy, P.A.; Lu, G.; Shiah, S.; Bollen, A.W.; Wang, R.A. Endothelial notch signaling is upregulated in human brain arteriovenous malformations and a mouse model of the disease. Lab. Investig. J. Tech. Methods Pathol. 2009, 89, 971–982.
181. Murphy, P.A.; Lam, M.T.; Wu, X.; Kim, T.N.; Vartanian, S.M.; Bollen, A.W.; Carlson, T.R.; Wang, R.A. Endothelial notch4 signaling induces hallmarks of brain arteriovenous malformations in mice. Proc. Natl. Acad. Sci. USA 2008, 105, 10901–10906.
182. Kim, H.; Su, H.; Weinsheimer, S.; Pawlikowska, L.; Young, W.L. Brain arteriovenous malformation pathogenesis: A response-to-injury paradigm. Acta Neurochir. Suppl. 2011, 111, 83–92.
183. Braverman, I.M.; Keh, A.; Jacobson, B.S. Ultrastructure and three-dimensional organization of the telangiectases of hereditary hemorrhagic telangiectasia. J. Investig. Dermatol. 1990, 95, 422–427.
184. Ouriel, K. Peripheral arterial disease. Lancet 2001, 358, 1257–1264.
185. Semenza, G.L. Vasculogenesis, angiogenesis, and arteriogenesis: Mechanisms of blood vessel formation and remodeling. J. Cell. Biochem. 2007, 102, 840–847.
186. Baltgalvis, K.A.; White, K.; Li, W.; Claypool, M.D.; Lang, W.; Alcantara, R.; Singh, B.K.; Friera, A.M.; McLaughlin, J.; Hansen, D.; et al. Exercise performance and peripheral vascular insufficiency improve with ampk activation in high-fat diet-fed mice. Am. J. Physiol. Heart Circ. Physiol. 2014, 306, H1128–H1145.
187. Niiyama, H.; Huang, N.F.; Rollins, M.D.; Cooke, J.P. Murine model of hindlimb ischemia. J. Vis. Exp. 2009, 23, doi:10.3791/1035.
188. + T-cells modulate collateral artery development. Arterioscler. Thromb. Vasc. Biol. 2007, 27, 2310–2318.
189. Couffinhal, T.; Silver, M.; Zheng, L.P.; Kearney, M.; Witzenbichler, B.; Isner, J.M. Mouse model of angiogenesis. Am. J. Pathol. 1998, 152, 1667–1679.
190. Brenes, R.A.; Jadlowiec, C.C.; Bear, M.; Hashim, P.; Protack, C.D.; Li, X.; Lv, W.; Collins, M.J.; Dardik, A. Toward a mouse model of hind limb ischemia to test therapeutic angiogenesis. J. Vasc. Surg. 2012, 56, 1669–1679.
191. Behm, C.Z.; Kaufmann, B.A.; Carr, C.; Lankford, M.; Sanders, J.M.; Rose, C.E.; Kaul, S.; Lindner, J.R. Molecular imaging of endothelial vascular cell adhesion molecule-1 expression and inflammatory cell recruitment during vasculogenesis and ischemia-mediated arteriogenesis. Circulation 2008, 117, 2902–2911.
192. Hellingman, A.A.; Bastiaansen, A.; de Vries, M.R.; Seghers, L.; Lijkwan, M.A.; Löwik, C.W.; Hamming, J.F.; Quax, P.H.A. Variations in surgical procedures for hind limb ischaemia mouse models result in differences in collateral formation. Eur. J. Vasc. Endovasc. Surg. 2010, 40, 796–803.
193. 1. J. Surg. Res. 2005, 129, 242–250.
194. Lawall, H.; Bramlage, P.; Amann, B. Stem cell and progenitor cell therapy in peripheral artery disease. A critical appraisal. Thromb. Haemost. 2010, 103, 696–709.
195. Tang, G.L.; Chang, D.S.; Sarkar, R.; Wang, R.; Messina, L.M. The effect of gradual or acute arterial occlusion on skeletal muscle blood flow, arteriogenesis, and inflammation in rat hindlimb ischemia. J. Vasc. Surg. 2005, 41, 312–320.
196. McGuigan, M.R.; Bronks, R.; Newton, R.U.; Sharman, M.J.; Graham, J.C.; Cody, D.V.; Kraemer, W.J. Muscle fiber characteristics in patients with peripheral arterial disease. Med. Sci. Sports Exerc. 2001, 33, 2016–2021.
197. Yang, Y.; Tang, G.; Yan, J.; Park, B.; Hoffman, A.; Tie, G.; Wang, R.; Messina, L.M. Cellular and molecular mechanism regulating blood flow recovery in acute versus gradual femoral artery occlusion are distinct in the mouse. J. Vasc. Surg. 2008, 48, 1546–1558.
198. Baffour, R.; Garb, J.L.; Kaufman, J.; Berman, J.; Rhee, S.W.; Norris, M.A.; Friedmann, P. Angiogenic therapy for the chronically ischemic lower limb in a rabbit model. J. Surg. Res. 2000, 93, 219–229.
199. Li, Y.; Hazarika, S.; Xie, D.; Pippen, A.M.; Kontos, C.D.; Annex, B.H. In mice with type 2 diabetes, a vascular endothelial growth factor (VEGF)-activating transcription factor modulates signaling and induces therapeutic angiogenesis after hindlimb ischemia. Diabetes 2007, 56, 656–665.
200. Hazarika, S.; Dokun, A.O.; Li, Y.; Popel, A.S.; Kontos, C.D.; Annex, B.H. Impaired angiogenesis after hindlimb ischemia in type 2 diabetes mellitus differential regulation of vascular endothelial growth factor receptor 1 and soluble vascular endothelial growth factor receptor 1. Circ. Res. 2007, 101, 948–956.
201. van Weel, V.; de Vries, M.; Voshol, P.J.; Verloop, R.E.; Eilers, P.H.C.; van Hinsbergh, V.W.M.; van Bockel, J.H.; Quax, P.H.A. Hypercholesterolemia reduces collateral artery growth more dominantly than hyperglycemia or insulin resistance in mice. Arterioscler. Thromb. Vasc. Biol. 2006, 26, 1383–1390.
202. Shimada, T.; Takeshita, Y.; Murohara, T.; Sasaki, K.; Egami, K.; Shintani, S.; Katsuda, Y.; Ikeda, H.; Nabeshima, Y.; Imaizumi, T. Angiogenesis and vasculogenesis are impaired in the precocious-aging klotho mouse. Circulation 2004, 110, 1148–1155.
203. Faber, J.E.; Zhang, H.; Lassance-Soares, R.M.; Prabhakar, P.; Najafi, A.H.; Burnett, M.S.; Epstein, S.E. Aging causes collateral rarefaction and increased severity of ischemic injury in multiple tissues. Arterioscler. Thromb. Vasc. Biol. 2011, 31, 1748–1756.
204. Peng, X.; Wang, J.; Lassance-Soares, R.M.; Najafi, A.H.; Sood, S.; Aghili, N.; Alderman, L.O.; Panza, J.A.; Faber, J.E.; Wang, S.; et al. Gender differences affect blood flow recovery in a mouse model of hindlimb ischemia. Am. J. Physiol. Heart Circ. Physiol. 2011, 300, H2027–H2034.
205. Carmeliet, P.; Ferreira, V.; Breier, G.; Pollefeyt, S.; Kieckens, L.; Gertsenstein, M.; Fahrig, M.; Vandenhoeck, A.; Harpal, K.; Eberhardt, C.; et al. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 1996, 380, 435–439.
206. Greve, J.M.; Chico, T.J.; Goldman, H.; Bunting, S.; Peale, F.V.; Daugherty, A.; van Bruggen, N.; Williams, S.P. Magnetic resonance angiography reveals therapeutic enlargement of collateral vessels induced by VEGF in a murine model of peripheral arterial disease. J. Magn. Reson. Imaging 2006, 24, 1124–1132.
207. Murohara, T.; Asahara, T.; Silver, M.; Bauters, C.; Masuda, H.; Kalka, C.; Kearney, M.; Chen, D.; Symes, J.F.; Fishman, M.C.; et al. Nitric oxide synthase modulates angiogenesis in response to tissue ischemia. J. Clin. Investig. 1998, 101, 2567–2578.
208. Park, B.; Hoffman, A.; Yang, Y.; Yan, J.; Tie, G.; Bagshahi, H.; Nowicki, P.T.; Messina, L.M. Enos affects both early and late collateral arterial adaptation and blood flow recovery after induction of hindlimb ischemia in mice. J. Vasc. Surg. 2010, 51, 165.
209. Hendgen-Cotta, U.B.; Luedike, P.; Totzeck, M.; Kropp, M.; Schicho, A.; Stock, P.; Rammos, C.; Niessen, M.; Heiss, C.; Lundberg, J.O.; et al. Dietary nitrate supplementation improves revascularization in chronic ischemia. Circulation 2012, 126, 1983–1992.
210. Mishima, T.; Ito, Y.; Hosono, K.; Tamura, Y.; Uchida, Y.; Hirata, M.; Suzsuki, T.; Amano, H.; Kato, S.; Kurihara, Y.; et al. Calcitonin gene-related peptide facilitates revascularization during hindlimb ischemia in mice. Am. J. Physiol. Heart Circ. Physiol. 2011, 300, H431–H439.
211. Cochain, C.; Rodero, M.P.; Vilar, J.; Recalde, A.; Richart, A.L.; Loinard, C.; Zouggari, Y.; Guerin, C.; Duriez, M.; Combadiere, B.; et al. Regulation of monocyte subset systemic levels by distinct chemokine receptors controls post-ischaemic neovascularization. Cardiovasc. Res. 2010, 88, 186–195.
212. Lloyd, P.G.; Prior, B.M.; Li, H.; Yang, H.T.; Terjung, R.L. VEGF receptor antagonism blocks arteriogenesis, but only partially inhibits angiogenesis, in skeletal muscle of exercise-trained rats. Am. J. Physiol. Heart Circ. Physiol. 2005, 288, H759–H768.
213. Yang, H.T.; Laughlin, M.H.; Terjung, R.L. Prior exercise training increases collateral-dependent blood flow in rats after acute femoral artery occlusion. Am. J. Physiol. Heart Circ. Physiol. 2000, 279, H1890–H1897.
214. Copp, S.W.; Hirai, D.M.; Schwagerl, P.J.; Musch, T.I.; Poole, D.C. Effects of neuronal nitric oxide synthase inhibition on resting and exercising hindlimb muscle blood flow in the rat. J. Physiol. 2010, 588, 1321–1331.
215. Cheng, X.W.; Kuzuya, M.; Kim, W.; Song, H.; Hu, L.; Inoue, A.; Nakamura, K.; Di, Q.; Sasaki, T.; Tsuzuki, M.; et al. Exercise training stimulates ischemia-induced neovascularization via phosphatidylinositol 3-kinase/Akt-dependent hypoxia-induced factor-1 α reactivation in mice of advanced age. Circulation 2010, 122, 707–716.
216. Rodriguez-Porcel, M.; Cai, W.; Gheysens, O.; Willmann, J.K.; Chen, K.; Wang, H.; Chen, I.Y.; He, L.; Wu, J.C.; Li, Z.-B. Imaging of vegf receptor in a rat myocardial infarction model using pet. J. Nucl. Med. 2008, 49, 667–673.
217. Leong-Poi, H.; Christiansen, J.; Heppner, P.; Lewis, C.W.; Klibanov, A.L.; Kaul, S.; Lindner, J.R. Assessment of endogenous and therapeutic arteriogenesis by contrast ultrasound molecular imaging of integrin expression. Circulation 2005, 111, 3248–3254.
218. Skajaa, T.; Cormode, D.P.; Falk, E.; Mulder, W.J.; Fisher, E.A.; Fayad, Z.A. High-density lipoprotein-based contrast agents for multimodal imaging of atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 2010, 30, 169–176.
219. Mulder, W.J.; Strijkers, G.J.; Briley-Saboe, K.C.; Frias, J.C.; Aguinaldo, J.G.; Vucic, E.; Amirbekian, V.; Tang, C.; Chin, P.T.; Nicolay, K.; et al. Molecular imaging of macrophages in atherosclerotic plaques using bimodal PEG-micelles. Magn. Reson. Med. 2007, 58, 1164–1170.
220. Majmudar, M.D.; Yoo, J.; Keliher, E.J.; Truelove, J.J.; Iwamoto, Y.; Sena, B.; Dutta, P.; Borodovsky, A.; Fitzgerald, K.; di Carli, M.F.; et al. Polymeric nanoparticle PET/MR imaging allows macrophage detection in atherosclerotic plaques. Circ. Res. 2013, 112, 755–761.
221. Tearney, G.J.; Yabushita, H.; Houser, S.L.; Aretz, H.T.; Jang, I.K.; Schlendorf, K.H.; Kauffman, C.R.; Shishkov, M.; Halpern, E.F.; Bouma, B.E. Quantification of macrophage content in atherosclerotic plaques by optical coherence tomography. Circulation 2003, 107, 113–119.
222. Douma, K.; Prinzen, L.; Slaaf, D.W.; Reutelingsperger, C.P.; Biessen, E.A.; Hackeng, T.M.; Post, M.J.; van Zandvoort, M.A. Nanoparticles for optical molecular imaging of atherosclerosis. Small 2009, 5, 544–557.
223. Duivenvoorden, R.; Tang, J.; Cormode, D.P.; Mieszawska, A.J.; Izquierdo-Garcia, D.; Ozcan, C.; Otten, M.J.; Zaidi, N.; Lobatto, M.E.; van Rijs, S.M.; et al. A statin-loaded reconstituted high-density lipoprotein nanoparticle inhibits atherosclerotic plaque inflammation. Nat. Commun. 2014, 5, doi:10.1038/ncomms4065.
224. Kukreja, A.; Lim, E.K.; Kang, B.; Choi, Y.; Lee, T.; Suh, J.S.; Huh, Y.M.; Haam, S. One-pot synthesis of magnetic nanoclusters enabling atherosclerosis-targeted magnetic resonance imaging. Int. J. Nanomed. 2014, 9, 2489–2498.
225. Kim, M.H.; Kim, B.; Lim, E.K.; Choi, Y.; Choi, J.; Kim, E.; Jang, E.; Park, H.S.; Suh, J.S.; Huh, Y.M.; et al. Magnetic nanoclusters engineered by polymer-controlled self-assembly for the accurate diagnosis of atherosclerotic plaques via magnetic resonance imaging. Macromol. Biosci. 2014, 14, 943–952.
226. Burtea, C.; Ballet, S.; Laurent, S.; Rousseaux, O.; Dencausse, A.; Gonzalez, W.; Port, M.; Corot, C.; Vander Elst, L.; Muller, R.N. Development of a magnetic resonance imaging protocol for the characterization of atherosclerotic plaque by using vascular cell adhesion molecule-1 and apoptosis-targeted ultrasmall superparamagnetic iron oxide derivatives. Arterioscler. Thromb. Vasc. Biol. 2012, 32, e36–e48.
227. Laing, S.T.; Moody, M.; Smulevitz, B.; Kim, H.; Kee, P.; Huang, S.; Holland, C.K.; McPherson, D.D. Ultrasound-enhanced thrombolytic effect of tissue plasminogen activator-loaded echogenic liposomes in an in vivo rabbit aorta thrombus model—Brief report. Arterioscler. Thromb. Vasc. Biol. 2011, 31, 1357–1359.
228. Kim, H.; Britton, G.L.; Peng, T.; Holland, C.K.; McPherson, D.D.; Huang, S.L. Nitric oxide-loaded echogenic liposomes for treatment of vasospasm following subarachnoid hemorrhage. Int. J. Nanomed. 2014, 9, 155–165.
229. Almutairi, A.; Rossin, R.; Shokeen, M.; Hagooly, A.; Ananth, A.; Capoccia, B.; Guillaudeu, S.; Abendschein, D.; Anderson, C.J.; Welch, M.J. Biodegradable dendritic positron-emitting nanoprobes for the noninvasive imaging of angiogenesis. Proc. Natl. Acad. Sci. USA 2009, 106, 685–690.
230. Mulder, W.J.; Jaffer, F.A.; Fayad, Z.A.; Nahrendorf, M. Imaging and nanomedicine in inflammatory atherosclerosis. Sci. Transl. Med. 2014, 6, 239sr231.
231. Press, M.C.; Jaffer, F.A. Molecular intravascular imaging approaches for atherosclerosis. Curr. Cardiovasc. Imaging Rep. 2014, 7, 9293.
232. Solomon, M.; Nothdruft, R.E.; Akers, W.; Edwards, W.B.; Liang, K.; Xu, B.; Suddlow, G.P.; Deghani, H.; Tai, Y.C.; Eggebrecht, A.T.; et al. Multimodal fluorescence-mediated tomography and spect/ct for small-animal imaging. J. Nucl. Med. 2013, 54, 639–646.
233. Poole, K.M.; Patil, C.A.; Nelson, C.E.; McCormack, D.R.; Madonna, M.C.; Duvall, C.L.; Skala, M.C. Longitudinal study of arteriogenesis with swept source optical coherence tomography and hyperspectral imaging. In Proceedings of the SPIE BiOS, International Society for Optics and Photonics, San Francisco, CA, USA, 4 March 2014.
234. Bouccara, S.; Sitbon, G.; Fragola, A.; Loriette, V.; Lequeux, N.; Pons, T. Enhancing fluorescence in vivo imaging using inorganic nanoprobes. Curr. Opin. Biotechnol. 2015, 34, 65–72.
235. Hong, G.; Lee, J.C.; Jha, A.; Diao, S.; Nakayama, K.H.; Hou, L.; Doyle, T.C.; Robinson, J.T.; Antaris, A.L.; Dai, H.; et al. Near-infrared ii fluorescence for imaging hindlimb vessel regeneration with dynamic tissue perfusion measurement. Circ. Cardiovasc. Imaging 2014, 7, 517–525.
236. Hong, G.; Lee, J.C.; Robinson, J.T.; Raaz, U.; Xie, L.; Huang, N.F.; Cooke, J.P.; Dai, H. Multifunctional in vivo vascular imaging using near-infrared ii fluorescence. Nat. Med. 2012, 18, 1841–1846.
237. Haka, A.S.; Potteaux, S.; Fraser, H.; Randolph, G.J.; Maxfield, F.R. Quantitative analysis of monocyte subpopulations in murine atherosclerotic plaques by multiphoton microscopy. PLoS ONE 2012, 7, e44823.
238. Engelbrecht, C.J.; Johnston, R.S.; Seibel, E.J.; Helmchen, F. Ultra-compact fiber-optic two-photon microscope for functional fluorescence imaging in vivo. Opt. Express 2008, 16, 5556–5564.
239. Xu, M.; Wang, L.V. Photoacoustic imaging in biomedicine. Rev. Sci. Instrum. 2006, 77, doi:10.1063/1.2195024.
240. Wang, L.V.; Hu, S. Photoacoustic tomography: In vivo imaging from organelles to organs. Science 2012, 335, 1458–1462.
241. Maslov, K.; Zhang, H.F.; Hu, S.; Wang, L.V. Optical-resolution photoacoustic microscopy for in vivo imaging of single capillaries. Opt. Lett. 2008, 33, 929–931.
242. Gamelin, J.; Maurudis, A.; Aguirre, A.; Huang, F.; Guo, P.; Wang, L.V.; Zhu, Q. A real-time photoacoustic tomography system for small animals. Opt. Express 2009, 17, 10489–10498.
243. Akers, W.J.; Kim, C.; Berezin, M.; Guo, K.; Fuhrhop, R.; Lanza, G.M.; Fischer, G.M.; Daltrozzo, E.; Zumbusch, A.; Cai, X.; et al. Noninvasive photoacoustic and fluorescence sentinel lymph node identification using dye-loaded perfluorocarbon nanoparticles. ACS Nano 2011, 5, 173–182.
244. Beard, P. Biomedical photoacoustic imaging. Interface Focus 2011, 1, 602–631.
245. Zhang, H.F.; Maslov, K.; Stoica, G.; Wang, L.V. Functional photoacoustic microscopy for high-resolution and noninvasive in vivo imaging. Nat. Biotechnol. 2006, 24, 848–851.
246. Wang, B.; Su, J.L.; Amirian, J.; Litovsky, S.H.; Smalling, R.; Emelianov, S. Detection of lipid in atherosclerotic vessels using ultrasound-guided spectroscopic intravascular photoacoustic imaging. Opt. Express 2010, 18, 4889–4897.
247. Grimaldi, V.; Schiano, C.; Casamassimi, A.; Zullo, A.; Soricelli, A.; Mancini, F.P.; Napoli, C. Imaging techniques to evaluate cell therapy in peripheral artery disease: State of the art and clinical trials. Clin. Physiol. Funct. Imaging 2014, doi:10.1111/cpf.12210.
248. Silvestre, J.S.; Smadja, D.M.; Levy, B.I. Postischemic revascularization: From cellular and molecular mechanisms to clinical applications. Physiol. Rev. 2013, 93, 1743–1802.
249. Sneider, E.B.; Nowicki, P.T.; Messina, L.M. Regenerative medicine in the treatment of peripheral arterial disease. J. Cell. Biochem. 2009, 108, 753–761.
250. Sharma, A.K.; Lu, G.; Jester, A.; Johnston, W.F.; Zhao, Y.; Hajzus, V.A.; Saadatzadeh, M.R.; Su, G.; Bhamidipati, C.M.; Mehta, G.S.; et al. Experimental abdominal aortic aneurysm formation is mediated by IL-17 and attenuated by mesenchymal stem cell treatment. Circulation 2012, 126, S38–S45.
251. Fu, X.M.; Yamawaki-Ogata, A.; Oshima, H.; Ueda, Y.; Usui, A.; Narita, Y. Intravenous administration of mesenchymal stem cells prevents angiotensin II-induced aortic aneurysm formation in apolipoprotein E-deficient mouse. J. Transl. Med. 2013, 11, 175.
252. Yamawaki-Ogata, A.; Fu, X.; Hashizume, R.; Fujimoto, K.L.; Araki, Y.; Oshima, H.; Narita, Y.; Usui, A. Therapeutic potential of bone marrow-derived mesenchymal stem cells in formed aortic aneurysms of a mouse model. Eur. J. Cardiol. Thorac. Surg. 2014, 45, e156–e165.
253. Norgren, L.; Hiatt, W.R.; Dormandy, J.A.A.; Nehler, M.R.; Harris, K.A.; Fowkes, F.G.R.; Tasc, I.I.W.G. Inter-society consensus for the management of peripheral arterial disease (tasc II). Eur. J. Vasc. Endovasc. Surg. 2007, 33, S1–S75.
254. Isner, J.M.; Asahara, T. Angiogenesis and vasculogenesis as therapeutic strategies for postnatal neovascularization. J. Clin. Investig. 1999, 103, doi:10.1172/JCI6889.
255. Huang, N.F.; Niiyama, H.; Peter, C.; de, A.; Natkunam, Y.; Fleissner, F.; Li, Z.; Rollins, M.D.; Wu, J.C.; Gambhir, S.S. Embryonic stem cell-derived endothelial cells engraft into the ischemic hindlimb and restore perfusion. Arterioscler. Thromb. Vasc. Biol. 2010, 30, 984–991.
256. Ishii, M.; Shibata, R.; Numaguchi, Y.; Kito, T.; Suzuki, H.; Shimizu, K.; Ito, A.; Honda, H.; Murohara, T. Enhanced angiogenesis by transplantation of mesenchymal stem cell sheet created by a novel magnetic tissue engineering method. Arterioscler. Thromb. Vasc. Biol. 2011, 31, 2210–2215.
257. Van der Bogt, K.E.A.; Hellingman, A.A.; Lijkwan, M.A.; Bos, E.-J.; de Vries, M.R.; van Rappard, J.R.M.; Fischbein, M.P.; Quax, P.H.; Robbins, R.C.; Hamming, J.F. Molecular imaging of bone marrow mononuclear cell survival and homing in murine peripheral artery disease. Cardiovasc. Imaging 2012, 5, 46–55.
258. Orbay, H.; Zhang, Y.; Hong, H.; Hacker, T.A.; Valdovinos, H.F.; Zagzebski, J.A.; Theuer, C.P.; Barnhart, T.E.; Cai, W. Positron emission tomography imaging of angiogenesis in a murine hindlimb ischemia model with 64Cu-labeled TRC105. Mol. Pharm. 2013, 10, 2749–2756.
259. Poole, K.M.; Tucker-Schwartz, J.M.; Sit, W.W.; Walsh, A.J.; Duvall, C.L.; Skala, M.C. Quantitative optical imaging of vascular response in vivo in a model of peripheral arterial disease. Am. J. Physiol. Heart Circ. Physiol. 2013, 305, H1168–H1180.